Mark Litzow
@MRLitzow
Followers
609
Following
4
Media
4
Statuses
27
I am a hematologist, professor of medicine and specialist in blood and marrow transplantation and in the treatment of acute and chronic leukemia
Mayo Clinic
Joined November 2012
Join us at Acute & Chronic Leukemias: Practical Applications 2023 on Oct. 6-7 in Orlando, FL (or via livestream). This year’s conference features interactive case presentations with panels of experts weighing in on pivotal treatment issues. Register here:
0
2
8
📣 #ESHALL2023 STARTS IN 1 MONTH! Don’t delay! REGISTER NOW & join us on May 19-21, 2023 in Berlin 🇩🇪 ➡ https://t.co/0alWOKoVPh 3rd Translational Research Conference: ACUTE LYMPHOBLASTIC LEUKAEMIA Chairs: @CoolsJn, @DombretHerve, @AdeleKFielding, @MRLitzow
#ESHCONFERENCES #LEUsm
0
3
3
Please consider attending the 3rd Translational Research Conference on ALL in Berlin May 19-21, 2023. Great line up of translational and clinical talks at #ESHALL2023.
0
1
8
Condolences to President Trump and his family on the death of his brother, Robert, yesterday.
0
0
3
Randomizes trial reported at ASCO shows benefit of early integrated palliative care for patients undergoing induction chemotherapy for AML! https://t.co/a2sVZYA9ik
0
5
23
via @NYTimes, interesting article on unreliability of many antibody tests for SARS-COV-2.
nytimes.com
A team of scientists worked around the clock to evaluate 14 antibody tests. A few worked as advertised. Most did not.
0
0
1
One silver lining of the pandemic......
nationalgeographic.com
Even before the coronavirus, air pollution killed seven million people a year. Will today's cleaner air inspire us to do better?
0
0
0
A lay statement from the New York Times on the unique pulmonary physiology of COVID-19.
0
0
1
Yes, correct, it was R-ibrutinib. Thanks for clarifying!
@MRLitzow @ASH_hematology Wasn't it R-Ibrutinib > FCR?
0
0
2
Big year for CLL at ASH 2018! Alliance-led NCTN trial shows Ibrutinib superior to BR in elderly (Plenary session) and ECOG-ACRIN-led NCTN trial shows superiority of Ibrutinib over FCR (LBA Session). And Michael Hallek is giving Ham Wasserman lecture on CLL. @ASH_hematology
2
22
61
#MayoFacDev at the Twitter class with one of my first Tweets @erhall1
2
0
2
@akeithstewart Keith, I joke that I became a hematologist because we don't have to deal with surgeons much! Mark @MRLitzow
0
0
0